Anne Wojcicki’s offer for sale 23andmeThe GENTESFIRMA, which she was looking for almost 20 years ago, received the Greenlight of the court.
This means that the non-profit TTAM research institute of Wojcicki “essentially all” from San Francisco resident 23andmes will acquire assets for $ 305 million. The transaction – which is more than three months after 23 and 23andme registered for chapter 11 bankruptcy – will be officially closed in the coming weeks.
“I am enthusiastic that TTAM will be able to build on the mission of 23Andme to help people bring access to, understand and benefit from human genome,” Wojcicki said In a statement on Monday – later: “The future of health care belongs to all of us.”
The sale that was approved by the US insolvency judge Brian C. Walsh on Friday Regeneron pharmaceuticals – a biotech company that had previously agreed to buy Most of 23andmes assets for 256 million US dollars in May. But Wojcicki’s non -profit organization later landed this offer and won the last round of the bidder, the last month.
As part of the deal, TTAM 23Andmes Signature “Personal Genome Service” will acquire, which is through the company’s saliva-based DNA test kits as well as research operations and its Lemonaid Health subsidiaries, a provider of Telemeth services, which is 23Andme previously planned get down.
Wojcicki had been working on taking 23andme privately for some time. Since the company has found a profitable business model since its public in 2021, it claimed that it would do a better market pressure outside the market. But this endeavor turned out to be a turbulent – especially in September last year, when All independent directors of 23Andme resigned from his board Referring to a “clear” disagreement with Wojcicki about the future of the company after recorded negotiations.
To 23andme’s March -InolvenzanchenWojcicki’s following efforts to acquire the company were unsuccessful. And when 23Andme submitted chapter 11 at the end of March, Wojcicki resigned as CEO and found at the time that she resigned as an independent bidder “in the best position”.
After Wojcicki’s non-profit organization 23 and 23 and unclear, it is unclear whether the co-founder will resign to the CEO seat. Although Wojcicki resigned months ago months ago, it has remained on the company’s board during the entire bankruptcy proceedings.
Over and beyond The financial tribes up to 23Ande insolvency, data protection concerns in connection with the genetic information of customers, also occurred – from the insolvency process, in particular with a data injury from 2023. But worry Which could mean new property for the personal data of the 23andMe user has broken up in recent months. At the time of its sales negotiation, the genetic test business had around 13 million customers, such as court documents.
In June, 27 states and the Columbia district Submitted a lawsuit Try to block the sale of personal genetic data through 23Ande without customer consent. And in a memorandum position, in which he describes his sale of 23andme to TTAM on Friday, Walsh recognized the objections of these states against the acquisition – but that had already been solved. Nevertheless, California, Kentucky, Tennessee, Texas and Utah are “still active against the sale”.
In a statement to politico On Monday, the California office, Attorney General Rob Bonta, claimed that the sale of 23Andme “does not correspond to the Genetic Data Protection Act in the state – and said that he was” disappointed “from the approval of the court and added that it rated the next steps.
The Associated Press turned to Bonta’s office on Tuesday to get further comments.
When announcing the intended sale to Wojcicki’s non -profit organization last month23Andme confirmed that TTAM “confirmed his obligation” to comply with the data protection guidelines and the applicable law of society. This means that TTAM will remain existing guidelines for consumer data, according to the company to which it enables users to delete their data and to “unsubscribe” research.
All customers will be at least two working days by e -mail before the acquisition by e -mail with details on data protection obligations and instructions from TTAM to delete data or to select research, said 23Andme. The company added that TTAM will offer customers for two years Expert Identity theft monitoring free of charge.
23Andme repeated these data protection guidelines on Monday. And Wojcicki added: “The core of my beliefs is that individuals should be authorized to have selection and transparency in terms of their genetic data and to have the opportunity to continue learning about their ancestors and health risks as they wish.”
